Teva announces launch of the first and only generic version of sandostatin® lar depot (octreotide acetate for injectable suspension), in the u.s.

Parsippany, n.j., oct. 01, 2024 (globe newswire) -- teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), announced today the launch of the first and only generic version of sandostatin®1 lar depot, in the united states.

TEVA Ratings Summary

TEVA Quant Ranking